NCT Number (or ClinicalTrials.gov Identifier)
See ClinicalTrials.gov Identifier (NCT Number).
READ MOREMultiple-Center Trial/Study
A clinical trial conducted according to a single protocol but at more than one site and therefore carried out by more than one investigator. (Pfizer)
READ MOREMonitoring
The act of overseeing the progress of a clinical study, and ensuring that it is conducted, recorded, and reported in accordance with the protocol, Standard Operating Procedures (SOPs), Good Clinical […]
READ MOREMonitor
Individual who acts as a liaison between the sponsor and the investigator of a clinical study, and who oversees the progress and conduct of the trial; may also be referred […]
READ MOREMaterial Transfer Agreement (MTA):
A contract, generally without funding, which provides a legal framework to govern the exchange of research materials between academic, government, and commercial organizations. The types of materials transferred under MTAs […]
READ MOREMasking (blinding)
A clinical trial design strategy in which one or more parties involved with the trial, such as the investigator or participant, do not know which participants have been assigned which […]
READ MORELast Verified Date
The last verified date is the most recent date that all of a clinical study’s information on ClinicalTrials.gov was confirmed as accurate and up to date. This date may be […]
READ MORELast Updated
The last updated date is the most recent date that changes to study information were submitted to ClinicalTrials.gov. There may be a delay of a few weeks before the updated […]
READ MOREKefauver-Harris Amendments
In 1962, the Kefauver-Harris Amendments were enacted to the Food, Drug and Cosmetic Act of 1938. These amendments address the protection of human subjects in clinical research and required the […]
READ MOREInvestigator Site File
The master file containing essential trial documents residing at the investigational site. (Pfizer)
READ MORE